- Investing Ideas
- German Pharmaceuticals & Biotech Healthy high growth potential
German Pharmaceuticals & Biotech Healthy high growth potential
Results
2
0 new
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
2 companies
Cantourage Group
Market Cap: €70.3m
Cantourage Group SE ist als medizinisches Cannabisunternehmen in Europa und international tätig.
HIGH
€5.64
7D
0.4%
1Y
39.3%
Formycon
Market Cap: €336.5m
Die Formycon AG, ein Biotechnologie-Unternehmen, entwickelt Biosimilar-Medikamente in Deutschland und der Schweiz.
FYB
€19.04
7D
0.7%
1Y
-25.0%